Fusion Antibodies is a Northern Ireland-based collaborative research organization that offers services including antibody discovery and cell line development.
Business Model:
Revenue: $5.7M
Employees: 201-500
Address: 1 Springbank Road
City: Belfast
State: northern ireland
Zip: BT17 0QL
Country: GB
Fusion Antibodies is a Northern Ireland-based collaborative research organization that offers services including antibody discovery and cell line development.
Contact Phone:
Contact Email:
Listed Exchange:
London Stock Exchange
IPO Date:
12/18/2017
Ticker Symbol:
FAB
IPO Price:
$1.0970824296897264/share
Amount Raised:
$7M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 5/2018 | Grant | $277.7k |
Invest Northern Ireland |
10/2020 | Grant | $245.1k |
Invest Northern Ireland |
5/2018 | Grant | 1 | - |
Invest Northern Ireland Invest Northern Ireland |
12/2017 | IPO | - | 9/2017 | Grant | $39.5k |
Invest Northern Ireland |
3/2017 | Grant | $56.9k |
Invest Northern Ireland |
7/2007 | Venture Round | 5 | $2.5M |
Invest Northern Ireland University Challenge Fund Clarendon Fund Managers Crescent Capital QUBIS Invest Northern Ireland University Challenge Fund Clarendon Fund Managers Crescent Capital QUBIS |
12/2017 | IPO | - | 5/2018 | Grant | 1 | - |
Invest Northern Ireland Invest Northern Ireland |
---|
Announced Date | Name | Price |
---|---|---|
5/2012 | Selexis SA |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|